{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T09:38:41Z","timestamp":1788687521634,"version":"build-2803163510"},"reference-count":134,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide (H\u2082S) are bioactive gasotransmitters implicated in migraine pathophysiology. These gases regulate vascular tone, nociceptive transmission, and inflammatory pathways, playing key roles in both the onset and modulation of migraine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This review synthesizes current evidence on the role of NO, CO, and H\u2082S in migraine, focusing on their molecular mechanisms, interactions, and potential therapeutic implications. Data from human and animal studies were analyzed to elucidate their contributions to migraine pathogenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>NO is a well-established migraine trigger, with NO donors such as nitroglycerin inducing headache and migraine attacks via cyclic guanosine monophosphate (cGMP)-dependent pathways. CO interacts with NO and cGMP signaling in pain modulation, contributing to central and peripheral nociceptive processing. H\u2082S exerts dual effects: while its interaction with NO forms nitroxyl (HNO), activating transient receptor potential ankyrin 1 (TRPA1) channels and triggering calcitonin gene-related peptide (CGRP) release; it also demonstrates neuroprotective properties through antioxidant mechanisms and nuclear factor erythroid 2-related factor 2 (Nrf2) activation. Additionally, epigenetic modifications of calcitonin gene-related peptide alpha (CALCA) have been implicated in migraine susceptibility, further supporting the role of these gasotransmitters in disease pathology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The interplay between NO, CO, and H\u2082S represents a critical aspect of migraine pathophysiology, influencing vascular, inflammatory, and nociceptive pathways. Understanding these gasotransmitters\u2019 roles may provide novel therapeutic targets for migraine management, particularly through modulation of TRPA1-CGRP signaling and oxidative stress pathways. Further research is warranted to explore their clinical applications in migraine treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/med-2025-1201","type":"journal-article","created":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T16:43:08Z","timestamp":1747586588000},"source":"Crossref","is-referenced-by-count":5,"title":["Neurogasobiology of migraine: Carbon monoxide, hydrogen sulfide, and nitric oxide as emerging pathophysiological trinacrium relevant to nociception regulation"],"prefix":"10.1515","volume":"20","author":[{"given":"Anastasiia","family":"Badaeva","sequence":"first","affiliation":[{"name":"Department for Pathological Physiology, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation , Moscow , Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Maiolino","sequence":"additional","affiliation":[{"name":"Department of Medical, Surgical Advanced Technologies \u201cG. F. Ingrassia\u201d, University of Catania , Catania , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Danilov","sequence":"additional","affiliation":[{"name":"Department for Nervous Diseases, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation , Moscow , Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Naprienko","sequence":"additional","affiliation":[{"name":"Department for Sport Medicines and Medical Rehabilitation, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation , Moscow , Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey","family":"Danilov","sequence":"additional","affiliation":[{"name":"Department for Nervous Diseases, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation , Moscow , Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula M.","family":"Jacob","sequence":"additional","affiliation":[{"name":"Institute of Regeneration and Prevention, Healthcare AG , Zurich , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Calabrese","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Biotechnological Sciences, University of Catania , Via Santa Sofia 97 , Catania , 95123 , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,5,17]]},"reference":[{"key":"2025122201304113384_j_med-2025-1201_ref_001","doi-asserted-by":"crossref","unstructured":"Tanaka M, Tuka B, V\u00e9csei L. Navigating the neurobiology of migraine: From pathways to potential therapies. Cells. 2024 Jun;13(13):1098.","DOI":"10.3390\/cells13131098"},{"key":"2025122201304113384_j_med-2025-1201_ref_002","doi-asserted-by":"crossref","unstructured":"Steiner TJ, Stovner LJ. Global epidemiology of migraine and its implications for public health and health policy. Nat Rev Neurol. 2023 Feb;19(2):109\u201317.","DOI":"10.1038\/s41582-022-00763-1"},{"key":"2025122201304113384_j_med-2025-1201_ref_003","doi-asserted-by":"crossref","unstructured":"Sutherland HG, Albury CL, Griffiths LR. Advances in genetics of migraine. J Headache Pain. 2019 Dec;20(1):72.","DOI":"10.1186\/s10194-019-1017-9"},{"key":"2025122201304113384_j_med-2025-1201_ref_004","doi-asserted-by":"crossref","unstructured":"Liu TH, Wang Z, Xie F, Liu YQ, Lin Q. Contributions of aversive environmental stress to migraine chronification: Research update of migraine pathophysiology. WJCC. 2021 Mar;9(9):2136\u201345.","DOI":"10.12998\/wjcc.v9.i9.2136"},{"key":"2025122201304113384_j_med-2025-1201_ref_005","doi-asserted-by":"crossref","unstructured":"Spekker E, Fejes-Szab\u00f3 A, Nagy-Gr\u00f3cz G. Models of trigeminal activation: Is there an animal model of migraine? Brain Sci. 2024 Mar;14(4):317.","DOI":"10.3390\/brainsci14040317"},{"key":"2025122201304113384_j_med-2025-1201_ref_006","doi-asserted-by":"crossref","unstructured":"Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of migraine: A disorder of sensory processing. Physiol Rev. 2017 Apr;97(2):553\u2013622.","DOI":"10.1152\/physrev.00034.2015"},{"key":"2025122201304113384_j_med-2025-1201_ref_007","doi-asserted-by":"crossref","unstructured":"Arngrim N, Schytz HW, Hauge MK, Ashina M, Olesen J. Carbon monoxide may be an important molecule in migraine and other headaches. Cephalalgia. 2014 Dec;34(14):1169\u201380.","DOI":"10.1177\/0333102414534085"},{"key":"2025122201304113384_j_med-2025-1201_ref_008","doi-asserted-by":"crossref","unstructured":"Neeb L, Reuter U. Nitric oxide in migraine. CNS Neurol Disord Drug Targets. 2007 Aug;6(4):258\u201364.","DOI":"10.2174\/187152707781387233"},{"key":"2025122201304113384_j_med-2025-1201_ref_009","doi-asserted-by":"crossref","unstructured":"Wild V, Messlinger K, Fischer MJM. Hydrogen sulfide determines HNO-induced stimulation of trigeminal afferents. Neurosci Lett. 2015 Aug;602:104\u20139.","DOI":"10.1016\/j.neulet.2015.06.056"},{"key":"2025122201304113384_j_med-2025-1201_ref_010","doi-asserted-by":"crossref","unstructured":"Bird A. Perceptions of epigenetics. Nature. 2007 May;447(7143):396\u20138.","DOI":"10.1038\/nature05913"},{"key":"2025122201304113384_j_med-2025-1201_ref_011","doi-asserted-by":"crossref","unstructured":"Jasrotia R, Kumar P, Kundal BR, Langer S. Insights into the role of epigenetic mechanisms in migraine: The future perspective of disease management. Nucleus. 2021 Dec;64(3):373\u201382.","DOI":"10.1007\/s13237-021-00366-z"},{"key":"2025122201304113384_j_med-2025-1201_ref_012","doi-asserted-by":"crossref","unstructured":"Sutherland HG, Buteri J, Menon S, Haupt LM, MacGregor EA, Lea RA, et al. Association study of the calcitonin gene-related polypeptide-alpha (CALCA) and the receptor activity modifying 1 (RAMP1) genes with migraine. Gene. 2013 Feb;515(1):187\u201392.","DOI":"10.1016\/j.gene.2012.11.053"},{"key":"2025122201304113384_j_med-2025-1201_ref_013","doi-asserted-by":"crossref","unstructured":"Durham PL. Inhibition of calcitonin gene\u2010related peptide function: A promising strategy for treating migraine. Headache. 2008 Sep;48(8):1269\u201375.","DOI":"10.1111\/j.1526-4610.2008.01215.x"},{"key":"2025122201304113384_j_med-2025-1201_ref_014","doi-asserted-by":"crossref","unstructured":"Edvinsson L. Novel migraine therapy with calcitonin gene-regulated peptide receptor antagonists. Expert Opin Ther Targets. 2007 Sep;11(9):1179\u201388.","DOI":"10.1517\/14728222.11.9.1179"},{"key":"2025122201304113384_j_med-2025-1201_ref_015","doi-asserted-by":"crossref","unstructured":"Zobdeh F, Eremenko II, Akan MA, Tarasov VV, Chubarev VN, Schi\u00f6th HB, et al. The epigenetics of migraine. IJMS. 2023 May;24(11):9127.","DOI":"10.3390\/ijms24119127"},{"key":"2025122201304113384_j_med-2025-1201_ref_016","doi-asserted-by":"crossref","unstructured":"Labruijere S, Stolk L, Verbiest M, De Vries R, Garrelds IM, Eilers PHC, et al. Methylation of migraine-related genes in different tissues of the rat. Shioda T, editor. PLoS One. 2014 Mar;9(3):e87616.","DOI":"10.1371\/journal.pone.0087616"},{"key":"2025122201304113384_j_med-2025-1201_ref_017","doi-asserted-by":"crossref","unstructured":"Oterino A, Valle N, Bravo Y, Mu\u00f1oz P, S\u00e1nchez-Velasco P, Ruiz-Alegr\u00eda C, et al. MTHFR T677 homozygosis influences the presence of aura in migraineurs. Cephalalgia. 2004 Jun;24(6):491\u20134.","DOI":"10.1111\/j.1468-2982.2004.00692.x"},{"key":"2025122201304113384_j_med-2025-1201_ref_018","doi-asserted-by":"crossref","unstructured":"Yamanaka G, Suzuki S, Morishita N, Takeshita M, Kanou K, Takamatsu T, et al. Role of neuroinflammation and blood-brain barrier permutability on migraine. IJMS. 2021 Aug;22(16):8929.","DOI":"10.3390\/ijms22168929"},{"key":"2025122201304113384_j_med-2025-1201_ref_019","doi-asserted-by":"crossref","unstructured":"Tora\u00f1o EG, Garc\u00eda MG, Fern\u00e1ndez-Morera JL, Ni\u00f1o-Garc\u00eda P, Fern\u00e1ndez AF. The impact of external factors on the epigenome: In Utero and over lifetime. BioMed Res Int. 2016;2016:1\u201317.","DOI":"10.1155\/2016\/2568635"},{"key":"2025122201304113384_j_med-2025-1201_ref_020","doi-asserted-by":"crossref","unstructured":"Badaeva AV, Danilov AB, Clayton P, Moskalev AA, Karasev AV, Tarasevich AF, et al. Perspectives on neuronutrition in prevention and treatment of neurological disorders. Nutrients. 2023 May;15(11):2505.","DOI":"10.3390\/nu15112505"},{"key":"2025122201304113384_j_med-2025-1201_ref_021","unstructured":"Pomierny B, Krzy\u017canowska W, Sk\u00f3rkowska A, Jurczyk J, Przejczowska-Pomierny K, Szafarz M, et al. Neuroprotection by post-stroke administration of the slow-releasing hydrogen sulfide (H2S) delivery molecule Ap39: Novel insight into stroke therapy."},{"key":"2025122201304113384_j_med-2025-1201_ref_022","doi-asserted-by":"crossref","unstructured":"Dogaru BG, Munteanu C. The role of hydrogen sulfide (H2S) in epigenetic regulation of neurodegenerative diseases: A systematic review. IJMS. 2023 Aug;24(16):12555.","DOI":"10.3390\/ijms241612555"},{"key":"2025122201304113384_j_med-2025-1201_ref_023","doi-asserted-by":"crossref","unstructured":"Xie J, Xie L, Wei H, Li XJ, Lin L. Dynamic regulation of DNA methylation and brain functions. Biology. 2023 Jan;12(2):152.","DOI":"10.3390\/biology12020152"},{"key":"2025122201304113384_j_med-2025-1201_ref_024","doi-asserted-by":"crossref","unstructured":"Wang Y, He Y, Hu X, Chi Q, Zhao B, Ye J, et al. Regulating of LncRNA2264\/miR-20b-5p\/IL17RD axis on hydrogen sulfide exposure-induced inflammation in broiler thymus by activating MYD88\/NF-\u03baB pathway. Toxicology. 2022 Feb;467:153086.","DOI":"10.1016\/j.tox.2021.153086"},{"key":"2025122201304113384_j_med-2025-1201_ref_025","doi-asserted-by":"crossref","unstructured":"Zeng M, Zhang T, Lin Y, Lin Y, Wu Z. The common LncRNAs of neuroinflammation-related diseases. Mol Pharmacol. 2023 Mar;103(3):113\u201331.","DOI":"10.1124\/molpharm.122.000530"},{"key":"2025122201304113384_j_med-2025-1201_ref_026","doi-asserted-by":"crossref","unstructured":"Eising E, A Datson N, Van Den Maagdenberg AM, Ferrari MD. Epigenetic mechanisms in migraine: A promising avenue? BMC Med. 2013 Dec;11(1):26.","DOI":"10.1186\/1741-7015-11-26"},{"key":"2025122201304113384_j_med-2025-1201_ref_027","doi-asserted-by":"crossref","unstructured":"Sch\u00fcrks M. Epigenetics in primary headaches: A new avenue for research. J Headache Pain. 2008 Jun;9(3):191\u20132.","DOI":"10.1007\/s10194-008-0039-5"},{"key":"2025122201304113384_j_med-2025-1201_ref_028","doi-asserted-by":"crossref","unstructured":"Raggi A, Leonardi M, Arruda M, Caponnetto V, Castaldo M, Coppola G, et al. Hallmarks of primary headache: part 1\u2013migraine. J Headache Pain. 2024;25(1):189. 10.1186\/s10194-024-01889-x.","DOI":"10.1186\/s10194-024-01889-x"},{"key":"2025122201304113384_j_med-2025-1201_ref_029","doi-asserted-by":"crossref","unstructured":"Kuburas A, Russo AF. Shared and independent roles of CGRP and PACAP in migraine pathophysiology. J Headache Pain. 2023 Apr;24(1):34.","DOI":"10.1186\/s10194-023-01569-2"},{"key":"2025122201304113384_j_med-2025-1201_ref_030","doi-asserted-by":"crossref","unstructured":"Wattiez AS, Sowers LP, Russo AF. Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting. Expert Opin Ther Targets. 2020 Feb;24(2):91\u2013100.","DOI":"10.1080\/14728222.2020.1724285"},{"key":"2025122201304113384_j_med-2025-1201_ref_031","doi-asserted-by":"crossref","unstructured":"Burstein R, Jakubowski M, Rauch SD. The science of migraine. J Vestib Res. 2011;21(6):305\u201314.","DOI":"10.3233\/VES-2012-0433"},{"key":"2025122201304113384_j_med-2025-1201_ref_032","doi-asserted-by":"crossref","unstructured":"Iyengar S, Ossipov MH, Johnson KW. The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine. Pain. 2017 Apr;158(4):543\u201359.","DOI":"10.1097\/j.pain.0000000000000831"},{"key":"2025122201304113384_j_med-2025-1201_ref_033","doi-asserted-by":"crossref","unstructured":"Labastida-Ram\u00edrez A, Caronna E, Gollion C, Stanyer E, Dapkute A, Braniste A, et al. Mode and site of action of therapies targeting CGRP signaling. J Headache Pain. 2023;24:125. 10.1186\/s10194-023-01644-8.","DOI":"10.1186\/s10194-023-01644-8"},{"key":"2025122201304113384_j_med-2025-1201_ref_034","doi-asserted-by":"crossref","unstructured":"Oliveira R, Gil-Gouveia R, Puledda F. CGRP-targeted medication in chronic migraine - systematic review. J Headache Pain. 2024 Apr;25(1):51.","DOI":"10.1186\/s10194-024-01753-y"},{"key":"2025122201304113384_j_med-2025-1201_ref_035","doi-asserted-by":"crossref","unstructured":"\u00d6zge A, Baykan B, B\u0131\u00e7ak\u00e7\u0131 \u015e, Erta\u015f M, Atalar A\u00c7, G\u00fcmr\u00fc S, et al. Revolutionizing migraine management: advances and challenges in CGRP-targeted therapies and their clinical implications. Front Neurol. 2024 Jun;15:1402569.","DOI":"10.3389\/fneur.2024.1402569"},{"key":"2025122201304113384_j_med-2025-1201_ref_036","doi-asserted-by":"crossref","unstructured":"Frimpong-Manson K, Ortiz YT, McMahon LR, Wilkerson JL. Advances in understanding migraine pathophysiology: a bench to bedside review of research insights and therapeutics. Front Mol Neurosci. 2024;17:1355281.","DOI":"10.3389\/fnmol.2024.1355281"},{"key":"2025122201304113384_j_med-2025-1201_ref_037","doi-asserted-by":"crossref","unstructured":"Gross EC, Lisicki M, Fischer D, S\u00e1ndor PS, Schoenen J. The metabolic face of migraine - from pathophysiology to treatment. Nat Rev Neurol. 2019 Nov;15(11):627\u201343.","DOI":"10.1038\/s41582-019-0255-4"},{"key":"2025122201304113384_j_med-2025-1201_ref_038","doi-asserted-by":"crossref","unstructured":"Del Moro L, Rota E, Pirovano E, Rainero I. Migraine, brain glucose metabolism and the \u201cneuroenergetic\u201d hypothesis: A scoping review. J Pain. 2022 Aug;23(8):1294\u2013317.","DOI":"10.1016\/j.jpain.2022.02.006"},{"key":"2025122201304113384_j_med-2025-1201_ref_039","doi-asserted-by":"crossref","unstructured":"Wang Y, Wang Y, Yue G, Zhao Y. Energy metabolism disturbance in migraine: From a mitochondrial point of view. Front Physiol. 2023 Apr;14:1133528.","DOI":"10.3389\/fphys.2023.1133528"},{"key":"2025122201304113384_j_med-2025-1201_ref_040","doi-asserted-by":"crossref","unstructured":"Eberhardt M, Dux M, Namer B, Miljkovic J, Cordasic N, Will C, et al. H2S and NO cooperatively regulate vascular tone by activating a neuroendocrine HNO\u2013TRPA1\u2013CGRP signalling pathway. Nat Commun. 2014 Jul;5(1):4381.","DOI":"10.1038\/ncomms5381"},{"key":"2025122201304113384_j_med-2025-1201_ref_041","doi-asserted-by":"crossref","unstructured":"Siracusa R, Voltarelli VA, Salinaro AT, Modafferi S, Cuzzocrea S, Calabrese EJ, et al. NO, CO and H2S: A trinacrium of bioactive gases in the brain. Biochem Pharmacol. 2022 Aug;202:115122.","DOI":"10.1016\/j.bcp.2022.115122"},{"key":"2025122201304113384_j_med-2025-1201_ref_042","doi-asserted-by":"crossref","unstructured":"Wu G, Meininger CJ, McNeal CJ, Bazer FW, Rhoads JM. Role of L-arginine in nitric oxide synthesis and health in humans. Adv Exp Med Biol. 2021;1332:167\u201387.","DOI":"10.1007\/978-3-030-74180-8_10"},{"key":"2025122201304113384_j_med-2025-1201_ref_043","doi-asserted-by":"crossref","unstructured":"Pradhan AA, Bertels Z, Akerman S. Targeted nitric oxide synthase inhibitors for migraine. Neurotherapeutics. 2018 Apr;15(2):391\u2013401.","DOI":"10.1007\/s13311-018-0614-7"},{"key":"2025122201304113384_j_med-2025-1201_ref_044","doi-asserted-by":"crossref","unstructured":"Burstein R, Jakubowski M. Unitary hypothesis for multiple triggers of the pain and strain of migraine. J Comp Neurol. 2005 Dec;493(1):9\u201314.","DOI":"10.1002\/cne.20688"},{"key":"2025122201304113384_j_med-2025-1201_ref_045","doi-asserted-by":"crossref","unstructured":"Olesen J. The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacol Ther. 2008 Nov;120(2):157\u201371.","DOI":"10.1016\/j.pharmthera.2008.08.003"},{"key":"2025122201304113384_j_med-2025-1201_ref_046","doi-asserted-by":"crossref","unstructured":"Benedicter N, Vogler B, Kuhn A, Schramm J, Mackenzie KD, Stratton J, et al. Glycerol trinitrate acts downstream of calcitonin gene-related peptide in trigeminal nociception\u2014evidence from rodent experiments with anti-CGRP antibody fremanezumab. Cells. 2024 Mar;13(7):572.","DOI":"10.3390\/cells13070572"},{"key":"2025122201304113384_j_med-2025-1201_ref_047","doi-asserted-by":"crossref","unstructured":"Ashina M. Migraine. N Engl J Med. 2020 Nov;383(19):1866\u201376.","DOI":"10.1056\/NEJMra1915327"},{"key":"2025122201304113384_j_med-2025-1201_ref_048","doi-asserted-by":"crossref","unstructured":"Ashina H, Christensen RH, Ashina M. Provoked versus spontaneous migraine attacks: pathophysiological similarities and differences. J Headache Pain. 2022 Dec;23(1):87.","DOI":"10.1186\/s10194-022-01464-2"},{"key":"2025122201304113384_j_med-2025-1201_ref_049","doi-asserted-by":"crossref","unstructured":"Chaudhary S, Singh L, Kaur M, Kadyan P. Genistein mitigates nitroglycerine-induced migraine: modulation of nitric oxide-mediated vasodilation and oxidative stress. Metab Brain Dis. 2024 May;39(5):821\u201331.","DOI":"10.1007\/s11011-024-01360-5"},{"key":"2025122201304113384_j_med-2025-1201_ref_050","unstructured":"Tassorelli C, Greco R, Morocutti A, Costa A, Nappi G. Nitric oxide-induced neuronal activation in the central nervous system as an animal model of migraine: mechanisms and mediators. Funct Neurol. 2001;16(4 Suppl):69\u201376."},{"key":"2025122201304113384_j_med-2025-1201_ref_051","doi-asserted-by":"crossref","unstructured":"Guo S, Ernstsen C, Hay-Schmidt A, Kristensen DM, Ashina M, Olesen J, et al. PACAP signaling is not involved in GTN- and levcromakalim-induced hypersensitivity in mouse models of migraine. J Headache Pain. 2022 Dec;23(1):155.","DOI":"10.1186\/s10194-022-01523-8"},{"key":"2025122201304113384_j_med-2025-1201_ref_052","doi-asserted-by":"crossref","unstructured":"Demartini C, Greco R, Zanaboni AM, Sances G, De Icco R, Borsook D, et al. Nitroglycerin as a comparative experimental model of migraine pain: From animal to human and back. Prog Neurobiol. 2019 Jun;177:15\u201332.","DOI":"10.1016\/j.pneurobio.2019.02.002"},{"key":"2025122201304113384_j_med-2025-1201_ref_053","doi-asserted-by":"crossref","unstructured":"Park S, Jung H, Han SW, Lee SH, Sohn JH. Differences in neuropathology between nitroglycerin-induced mouse models of episodic and chronic migraine. IJMS. 2024 Mar;25(7):3706.","DOI":"10.3390\/ijms25073706"},{"key":"2025122201304113384_j_med-2025-1201_ref_054","doi-asserted-by":"crossref","unstructured":"Bandara SMR, Samita S, Kiridana AM, Herath HMMTB. Elevated nitric oxide and carbon monoxide concentration in nasal-paranasal sinus air as a diagnostic tool of migraine: A case \u2013 control study. BMC Neurol. 2021 Dec;21(1):407.","DOI":"10.1186\/s12883-021-02434-y"},{"key":"2025122201304113384_j_med-2025-1201_ref_055","doi-asserted-by":"crossref","unstructured":"Sureda-Gibert P, Romero-Reyes M, Akerman S. Nitroglycerin as a model of migraine: Clinical and preclinical review. Neurobiol Pain. 2022 Aug;12:100105.","DOI":"10.1016\/j.ynpai.2022.100105"},{"key":"2025122201304113384_j_med-2025-1201_ref_056","doi-asserted-by":"crossref","unstructured":"Casili G, Lanza M, Filippone A, Campolo M, Paterniti I, Cuzzocrea S, et al. Dimethyl fumarate alleviates the nitroglycerin (NTG)-induced migraine in mice. J Neuroinflamm. 2020 Dec;17(1):59.","DOI":"10.1186\/s12974-020-01736-1"},{"key":"2025122201304113384_j_med-2025-1201_ref_057","doi-asserted-by":"crossref","unstructured":"Tassorelli C, Joseph SA. Systemic nitroglycerin induces Fos immunoreactivity in brainstem and forebrain structures of the rat. Brain Res. 1995 Jun;682(1\u20132):167\u201381.","DOI":"10.1016\/0006-8993(95)00348-T"},{"key":"2025122201304113384_j_med-2025-1201_ref_058","doi-asserted-by":"crossref","unstructured":"Pardutz A, Szatm\u00e1ri E, Vecsei L, Schoenen J. Nitroglycerin-induced nNOS increase in rat trigeminal nucleus caudalis is inhibited by systemic administration of lysine acetylsalicylate but not of sumatriptan. Cephalalgia. 2004 Jun;24(6):439\u201345.","DOI":"10.1111\/j.1468-2982.2004.00699.x"},{"key":"2025122201304113384_j_med-2025-1201_ref_059","doi-asserted-by":"crossref","unstructured":"Marsh N, Marsh A. A short history of nitroglycerine and nitric oxide in pharmacology and physiology. Clin Exp Pharma Physio. 2000 Apr;27(4):313\u20139.","DOI":"10.1046\/j.1440-1681.2000.03240.x"},{"key":"2025122201304113384_j_med-2025-1201_ref_060","doi-asserted-by":"crossref","unstructured":"Tassorelli C, Joseph SA, Buzzi MG, Nappi G. The effects on the central nervous system of nitroglycerin\u2014putative mechanisms and mediators. Prog Neurobiol. 1999 Apr;57(6):607\u201324.","DOI":"10.1016\/S0301-0082(98)00071-9"},{"key":"2025122201304113384_j_med-2025-1201_ref_061","doi-asserted-by":"crossref","unstructured":"Mason BN, Hassler SN, DeFea K, Boitano S, Vagner J, Price TJ, et al. PAR2 activation in the dura causes acute behavioral responses and priming to glyceryl trinitrate in a mouse migraine model. J Headache Pain. 2023 Apr;24(1):42.","DOI":"10.1186\/s10194-023-01574-5"},{"key":"2025122201304113384_j_med-2025-1201_ref_062","doi-asserted-by":"crossref","unstructured":"Lambert GA, Donaldson C, Boers PM, Zagami AS. Activation of trigeminovascular neurons by glyceryl trinitrate. Brain Res. 2000 Dec;887(1):203\u201310.","DOI":"10.1016\/S0006-8993(00)02919-X"},{"key":"2025122201304113384_j_med-2025-1201_ref_063","doi-asserted-by":"crossref","unstructured":"Koroleva K, Svitko S, Ananev A, Buglinina A, Bogatova K, Yakovleva O, et al. Effects of nitric oxide on the activity of P2X and TRPV1 receptors in rat meningeal afferents of the trigeminal nerve. IJMS. 2023 Apr;24(8):7519.","DOI":"10.3390\/ijms24087519"},{"key":"2025122201304113384_j_med-2025-1201_ref_064","doi-asserted-by":"crossref","unstructured":"Giniatullin R, Nistri A. Role of ATP in migraine mechanisms: Focus on P2X3 receptors. J Headache Pain. 2023 Jan;24(1):1.","DOI":"10.1186\/s10194-022-01535-4"},{"key":"2025122201304113384_j_med-2025-1201_ref_065","doi-asserted-by":"crossref","unstructured":"Fila M, Przyslo L, Derwich M, Sobczuk P, Pawlowska E, Blasiak J. The TRPA1 ion channel mediates oxidative stress-related migraine pathogenesis. Molecules. 2024 Jul;29(14):3385.","DOI":"10.3390\/molecules29143385"},{"key":"2025122201304113384_j_med-2025-1201_ref_066","doi-asserted-by":"crossref","unstructured":"Moye LS, Tipton AF, Dripps I, Sheets Z, Crombie A, Violin JD, et al. Delta opioid receptor agonists are effective for multiple types of headache disorders. Neuropharmacology. 2019 Apr;148:77\u201386.","DOI":"10.1016\/j.neuropharm.2018.12.017"},{"key":"2025122201304113384_j_med-2025-1201_ref_067","doi-asserted-by":"crossref","unstructured":"Guo Z, Czerpaniak K, Zhang J, Cao YQ. Increase in trigeminal ganglion neurons that respond to both calcitonin gene\u2013related peptide and pituitary adenylate cyclase\u2013activating polypeptide in mouse models of chronic migraine and posttraumatic headache. Pain. 2021 May;162(5):1483\u201399.","DOI":"10.1097\/j.pain.0000000000002147"},{"key":"2025122201304113384_j_med-2025-1201_ref_068","doi-asserted-by":"crossref","unstructured":"Pradhan AA, Smith ML, McGuire B, Tarash I, Evans CJ, Charles A. Characterization of a novel model of chronic migraine. Pain. 2014 Feb;155(2):269\u201374.","DOI":"10.1016\/j.pain.2013.10.004"},{"key":"2025122201304113384_j_med-2025-1201_ref_069","doi-asserted-by":"crossref","unstructured":"Olesen J, Ashina M. Can nitric oxide induce migraine in normal individuals? Cephalalgia. 2015 Oct;35(12):1125\u20139.","DOI":"10.1177\/0333102414566201"},{"key":"2025122201304113384_j_med-2025-1201_ref_070","doi-asserted-by":"crossref","unstructured":"Miyamoto T, Dubin AE, Petrus MJ, Patapoutian A. TRPV1 and TRPA1 mediate peripheral nitric oxide-induced nociception in mice. Premkumar LS, editor. PLoS One. 2009 Oct;4(10):e7596.","DOI":"10.1371\/journal.pone.0007596"},{"key":"2025122201304113384_j_med-2025-1201_ref_071","doi-asserted-by":"crossref","unstructured":"Messlinger K, Lennerz JK, Eberhardt M, Fischer MJM. CGRP and NO in the trigeminal system: Mechanisms and role in headache generation. Headache. 2012 Oct;52(9):1411\u201327.","DOI":"10.1111\/j.1526-4610.2012.02212.x"},{"key":"2025122201304113384_j_med-2025-1201_ref_072","doi-asserted-by":"crossref","unstructured":"Akerman S, Williamson DJ, Kaube H, Goadsby PJ. Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene\u2010related peptide induced dilation of dural meningeal vessels. Br J Pharmacol. 2002 Sep;137(1):62\u20138.","DOI":"10.1038\/sj.bjp.0704842"},{"key":"2025122201304113384_j_med-2025-1201_ref_073","doi-asserted-by":"crossref","unstructured":"Zupan M, Zaletel M, Viso\u010dnik D, \u017dvan B. Calcitonin gene\u2010related peptide\u2010induced hemodynamic changes in migraine with and without aura. Acta Neurol Scand. 2021 Dec;144(6):616\u201322.","DOI":"10.1111\/ane.13495"},{"key":"2025122201304113384_j_med-2025-1201_ref_074","doi-asserted-by":"crossref","unstructured":"Juhasz G, Zsombok T, Modos EA, Olajos S, Jakab B, Nemeth J, et al. NO-induced migraine attack: Strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release. Pain. 2003 Dec;106(3):461\u201370.","DOI":"10.1016\/j.pain.2003.09.008"},{"key":"2025122201304113384_j_med-2025-1201_ref_075","doi-asserted-by":"crossref","unstructured":"Thomsen L. Investigations into the role of nitric oxide and the large intracranial arteries in migraine headache. Cephalalgia. 1997 Dec;17(8):873\u201395.","DOI":"10.1046\/j.1468-2982.1997.1708873.x"},{"key":"2025122201304113384_j_med-2025-1201_ref_076","doi-asserted-by":"crossref","unstructured":"Lassen L, Ashina M, Christiansen I, Ulrich V, Olesen J. Nitric oxide synthase inhibition in migraine. Lancet. 1997 Feb;349(9049):401\u20132.","DOI":"10.1016\/S0140-6736(97)80021-9"},{"key":"2025122201304113384_j_med-2025-1201_ref_077","doi-asserted-by":"crossref","unstructured":"Olesen J. Provocation of attacks to discover migraine signaling mechanisms and new drug targets: early history and future perspectives - A narrative review. J Headache Pain. 2024 Jun;25(1):105.","DOI":"10.1186\/s10194-024-01796-1"},{"key":"2025122201304113384_j_med-2025-1201_ref_078","doi-asserted-by":"crossref","unstructured":"Iversen HK. N-Acetylcysteine enhances nitroglycerin-induced headache and cranial arterial responses. Clin Pharmacol Ther. 1992 Aug;52(2):125\u201333.","DOI":"10.1038\/clpt.1992.121"},{"key":"2025122201304113384_j_med-2025-1201_ref_079","doi-asserted-by":"crossref","unstructured":"Karsan N, Bose PR, Thompson C, Newman J, Goadsby PJ. Headache and non-headache symptoms provoked by nitroglycerin in migraineurs: A human pharmacological triggering study. Cephalalgia. 2020 Jul;40(8):828\u201341.","DOI":"10.1177\/0333102420910114"},{"key":"2025122201304113384_j_med-2025-1201_ref_080","doi-asserted-by":"crossref","unstructured":"Afridi KS, Kaube H, Goadsby JP. Glyceryl trinitrate triggers premonitory symptoms in migraineurs. Pain. 2004 Aug;110(3):675\u201380.","DOI":"10.1016\/j.pain.2004.05.007"},{"key":"2025122201304113384_j_med-2025-1201_ref_081","doi-asserted-by":"crossref","unstructured":"Sances G, Tassorelli C, Pucci E, Ghiotto N, Sandrini G, Nappi G. Reliability of the nitroglycerin provocative test in the diagnosis of neurovascular headaches. Cephalalgia. 2004 Feb;24(2):110\u20139.","DOI":"10.1111\/j.1468-2982.2004.00639.x"},{"key":"2025122201304113384_j_med-2025-1201_ref_082","doi-asserted-by":"crossref","unstructured":"Karsan N, Gosalia H, Goadsby PJ. Molecular mechanisms of migraine: Nitric oxide synthase and neuropeptides. IJMS. 2023 Jul;24(15):11993.","DOI":"10.3390\/ijms241511993"},{"key":"2025122201304113384_j_med-2025-1201_ref_083","doi-asserted-by":"crossref","unstructured":"Garthwaite J, Boulton CL. Nitric oxide signaling in the central nervous system. Annu Rev Physiol. 1995 Oct;57(1):683\u2013706.","DOI":"10.1146\/annurev.ph.57.030195.003343"},{"key":"2025122201304113384_j_med-2025-1201_ref_084","doi-asserted-by":"crossref","unstructured":"D\u2019Andrea G, Gucciardi A, Giordano G, Bussone G, Leon A. Study of arginine metabolism in medication overuse chronic migraine: possible defect in NO synthesis. Neurol Sci. 2022 Apr;43(4):2745\u20139.","DOI":"10.1007\/s10072-021-05672-7"},{"key":"2025122201304113384_j_med-2025-1201_ref_085","doi-asserted-by":"crossref","unstructured":"Liu L, Li W, Wang L, Gong P, Lyu T, Liu D, et al. Proteomic and metabolomic profiling of acupuncture for migraine reveals a correlative link via energy metabolism. Front Neurosci. 2022;16:1013328.","DOI":"10.3389\/fnins.2022.1013328"},{"key":"2025122201304113384_j_med-2025-1201_ref_086","doi-asserted-by":"crossref","unstructured":"Sabour S, Harzand-Jadidi S, Jafari-Khounigh A, Zarea Gavgani V, Sedaghat Z, Alavi N. The association between ambient air pollution and migraine: A systematic review. Environ Monit Assess. 2024 Mar;196(3):271.","DOI":"10.1007\/s10661-024-12376-w"},{"key":"2025122201304113384_j_med-2025-1201_ref_087","doi-asserted-by":"crossref","unstructured":"Siracusa R, Schaufler A, Calabrese V, Fuller PM, Otterbein LE. Carbon monoxide: From poison to clinical trials. Trends Pharmacol Sci. 2021 May;42(5):329\u201339.","DOI":"10.1016\/j.tips.2021.02.003"},{"key":"2025122201304113384_j_med-2025-1201_ref_088","doi-asserted-by":"crossref","unstructured":"Wallace JL, Ianaro A, De Nucci G. Gaseous mediators in gastrointestinal mucosal defense and injury. Dig Dis Sci. 2017 Sep;62(9):2223\u201330.","DOI":"10.1007\/s10620-017-4681-0"},{"key":"2025122201304113384_j_med-2025-1201_ref_089","doi-asserted-by":"crossref","unstructured":"Motterlini R, Otterbein LE. The therapeutic potential of carbon monoxide. Nat Rev Drug Discov. 2010 Sep;9(9):728\u201343.","DOI":"10.1038\/nrd3228"},{"key":"2025122201304113384_j_med-2025-1201_ref_090","doi-asserted-by":"crossref","unstructured":"Ghanizada H, Arngrim N, Schytz HW, Olesen J, Ashina M. Carbon monoxide inhalation induces headache but no migraine in patients with migraine without aura. Cephalalgia. 2018 Nov;38(13):1940\u20139.","DOI":"10.1177\/0333102418765771"},{"key":"2025122201304113384_j_med-2025-1201_ref_091","doi-asserted-by":"crossref","unstructured":"Kanburoglu MK, Cizmeci MN, Akelma AZ. A rare cause of chronic headache that may be misdiagnosed as migraine: Chronic carbon monoxide poisoning. Turk J Emerg Med. 2014 Sep;14(3):132\u20134.","DOI":"10.5505\/1304.7361.2014.00868"},{"key":"2025122201304113384_j_med-2025-1201_ref_092","doi-asserted-by":"crossref","unstructured":"Li X, Clark JD. Spinal cord nitric oxide synthase and heme oxygenase limit morphine induced analgesia. Brain Res Mol Brain Res. 2001 Nov;95(1\u20132):96\u2013102.","DOI":"10.1016\/S0169-328X(01)00251-0"},{"key":"2025122201304113384_j_med-2025-1201_ref_093","doi-asserted-by":"crossref","unstructured":"Mancuso C, Pistritto G, Tringali G, Grossman AB, Preziosi P, Navarra P. Evidence that carbon monoxide stimulates prostaglandin endoperoxide synthase activity in rat hypothalamic explants and in primary cultures of rat hypothalamic astrocytes. Brain Res Mol Brain Res. 1997 May;45(2):294\u2013300.","DOI":"10.1016\/S0169-328X(96)00258-6"},{"key":"2025122201304113384_j_med-2025-1201_ref_094","doi-asserted-by":"crossref","unstructured":"Hampson NB, Hampson LA. Characteristics of headache associated with acute carbon monoxide poisoning. Headache. 2002 Mar;42(3):220\u20133.","DOI":"10.1046\/j.1526-4610.2002.02055.x"},{"key":"2025122201304113384_j_med-2025-1201_ref_095","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013 Jul;33(9):629\u2013808.","DOI":"10.1177\/0333102413485658"},{"key":"2025122201304113384_j_med-2025-1201_ref_096","doi-asserted-by":"crossref","unstructured":"Cebeci H, Durmaz MS, Arslan S, Arslan A, Tekin AF, Habibi HA, et al. Diagnostic utility of arterial spin labeling in identifying changes in brain perfusion in patients with carbon monoxide poisoning. Clin Imaging. 2020 Aug;64:92\u20136.","DOI":"10.1016\/j.clinimag.2020.04.006"},{"key":"2025122201304113384_j_med-2025-1201_ref_097","doi-asserted-by":"crossref","unstructured":"Komuro T, Borsody MK, Ono S, Marton LS, Weir BK, Zhang ZD, et al. The vasorelaxation of cerebral arteries by carbon monoxide. Exp Biol Med (Maywood). 2001 Oct;226(9):860\u20135.","DOI":"10.1177\/153537020122600909"},{"key":"2025122201304113384_j_med-2025-1201_ref_098","doi-asserted-by":"crossref","unstructured":"Al-Karagholi MA, Arngrim N, Ashina M. Migraine headache and aura induced by hypoxia. J Physiol. 2024 Nov;602(21):5515\u201322.","DOI":"10.1113\/JP284553"},{"key":"2025122201304113384_j_med-2025-1201_ref_099","doi-asserted-by":"crossref","unstructured":"Arngrim N, Schytz HW, Britze J, Vestergaard MB, Sander M, Olsen KS, et al. Carbon monoxide inhalation induces headache in a human headache model. Cephalalgia. 2018 Apr;38(4):697\u2013706.","DOI":"10.1177\/0333102417708768"},{"key":"2025122201304113384_j_med-2025-1201_ref_100","doi-asserted-by":"crossref","unstructured":"Lipton RB, Mazer C, Newman LC, Solomon S. Sumatriptan relieves migrainelike headaches associated with carbon monoxide exposure. Headache. 1997 Jun;37(6):392\u20135.","DOI":"10.1046\/j.1526-4610.1997.3706392.x"},{"key":"2025122201304113384_j_med-2025-1201_ref_101","doi-asserted-by":"crossref","unstructured":"Ashina M. Nitric oxide-induced headache in patients with chronic tension-type headache. Brain. 2000 Sep;123(9):1830\u20137.","DOI":"10.1093\/brain\/123.9.1830"},{"key":"2025122201304113384_j_med-2025-1201_ref_102","doi-asserted-by":"crossref","unstructured":"Dioum EM, Rutter J, Tuckerman JR, Gonzalez G, Gilles-Gonzalez MA, McKnight SL. NPAS2: A gas-responsive transcription factor. Science. 2002 Dec;298(5602):2385\u20137.","DOI":"10.1126\/science.1078456"},{"key":"2025122201304113384_j_med-2025-1201_ref_103","doi-asserted-by":"crossref","unstructured":"Jim\u00e9nez-Jim\u00e9nez FJ, Alonso-Navarro H, Garc\u00eda-Mart\u00edn E, Espada-Rubio S, Ag\u00fandez JAG. Oxidative stress and migraine. Mol Neurobiol. 2024 Oct;61(10):8344\u201360.","DOI":"10.1007\/s12035-024-04114-7"},{"key":"2025122201304113384_j_med-2025-1201_ref_104","doi-asserted-by":"crossref","unstructured":"Angelova PR, Myers I, Abramov AY. Carbon monoxide neurotoxicity is triggered by oxidative stress induced by ROS production from three distinct cellular sources. Redox Biol. 2023 Apr;60:102598.","DOI":"10.1016\/j.redox.2022.102598"},{"key":"2025122201304113384_j_med-2025-1201_ref_105","doi-asserted-by":"crossref","unstructured":"Zhao Z, Guo W, Xu C, Wang Q, Mao C, Wan M. Physiological functions and donor design of hydrogen sulfide and its application in central nervous system diseases. Chem Eng J. 2023 Jan;452:139089.","DOI":"10.1016\/j.cej.2022.139089"},{"key":"2025122201304113384_j_med-2025-1201_ref_106","doi-asserted-by":"crossref","unstructured":"Mulay P, Chen C, Krishna V. Enzyme-independent catabolism of cysteine with pyridoxal-5\u2032-phosphate. Sci Rep. 2023 Jan;13(1):312.","DOI":"10.1038\/s41598-022-26966-6"},{"key":"2025122201304113384_j_med-2025-1201_ref_107","doi-asserted-by":"crossref","unstructured":"Coletta C, Papapetropoulos A, Erdelyi K, Olah G, M\u00f3dis K, Panopoulos P, et al. Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation. Proc Natl Acad Sci USA. 2012 Jun;109(23):9161\u20136.","DOI":"10.1073\/pnas.1202916109"},{"key":"2025122201304113384_j_med-2025-1201_ref_108","doi-asserted-by":"crossref","unstructured":"Yong QC, Cheong JL, Hua F, Deng LW, Khoo YM, Lee HS, et al. Regulation of heart function by endogenous gaseous mediators\u2014Crosstalk between nitric oxide and hydrogen sulfide. Antioxid Redox Signal. 2011 Jun;14(11):2081\u201391.","DOI":"10.1089\/ars.2010.3572"},{"key":"2025122201304113384_j_med-2025-1201_ref_109","doi-asserted-by":"crossref","unstructured":"Teicher C, De Col R, Messlinger K. Hydrogen sulfide mediating both excitatory and inhibitory effects in a rat model of meningeal nociception and headache generation. Front Neurol. 2017 Jul;8:336.","DOI":"10.3389\/fneur.2017.00336"},{"key":"2025122201304113384_j_med-2025-1201_ref_110","doi-asserted-by":"crossref","unstructured":"Huang D, Li S, Dhaka A, Story GM, Cao YQ. Expression of the transient receptor potential channels TRPV1, TRPA1 and TRPM8 in mouse trigeminal primary afferent neurons innervating the dura. Mol Pain. 2012 Jan;8:1744-8069-8\u201366.","DOI":"10.1186\/1744-8069-8-66"},{"key":"2025122201304113384_j_med-2025-1201_ref_111","doi-asserted-by":"crossref","unstructured":"Story GM, Peier AM, Reeve AJ, Eid SR, Mosbacher J, Hricik TR, et al. ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell. 2003 Mar;112(6):819\u201329.","DOI":"10.1016\/S0092-8674(03)00158-2"},{"key":"2025122201304113384_j_med-2025-1201_ref_112","doi-asserted-by":"crossref","unstructured":"Sarchielli P, Alberti A, Codini M, Floridi A, Gallai V. Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia. 2000 Dec;20(10):907\u201318.","DOI":"10.1046\/j.1468-2982.2000.00146.x"},{"key":"2025122201304113384_j_med-2025-1201_ref_113","doi-asserted-by":"crossref","unstructured":"Moschiano F, D\u2019Amico D, Usai S, Grazzi L, Di Stefano M, Ciusani E, et al. Homocysteine plasma levels in patients with migraine with aura. Neurol Sci. 2008 May;29(S1):173\u20135.","DOI":"10.1007\/s10072-008-0917-2"},{"key":"2025122201304113384_j_med-2025-1201_ref_114","doi-asserted-by":"crossref","unstructured":"Bigal ME, Walter S, Rapoport AM. Calcitonin gene\u2010related peptide (CGRP) and migraine current understanding and state of development. Headache. 2013 Sep;53(8):1230\u201344.","DOI":"10.1111\/head.12179"},{"key":"2025122201304113384_j_med-2025-1201_ref_115","doi-asserted-by":"crossref","unstructured":"Souza Monteiro De Araujo D, Nassini R, Geppetti P, De Logu F. TRPA1 as a therapeutic target for nociceptive pain. Expert Opin Ther Targets. 2020 Oct;24(10):997\u20131008.","DOI":"10.1080\/14728222.2020.1815191"},{"key":"2025122201304113384_j_med-2025-1201_ref_116","doi-asserted-by":"crossref","unstructured":"Strassman AM, Raymond SA, Burstein R. Sensitization of meningeal sensory neurons and the origin of headaches. Nature. 1996 Dec;384(6609):560\u20134.","DOI":"10.1038\/384560a0"},{"key":"2025122201304113384_j_med-2025-1201_ref_117","doi-asserted-by":"crossref","unstructured":"Waeber C, Moskowitz MA. Migraine as an inflammatory disorder. Neurology. 2005 May;64(10 Suppl 2):S9\u201315.","DOI":"10.1212\/WNL.64.10_suppl_2.S9"},{"key":"2025122201304113384_j_med-2025-1201_ref_118","doi-asserted-by":"crossref","unstructured":"Matsunami M, Tarui T, Mitani K, Nagasawa K, Fukushima O, Okubo K, et al. Luminal hydrogen sulfide plays a pronociceptive role in mouse colon. Gut. 2009 Jun;58(6):751\u201361.","DOI":"10.1136\/gut.2007.144543"},{"key":"2025122201304113384_j_med-2025-1201_ref_119","doi-asserted-by":"crossref","unstructured":"Distrutti E. Hydrogen sulphide and pain. IADT. 2011 Apr;10(2):123\u201332.","DOI":"10.2174\/187152811794776240"},{"key":"2025122201304113384_j_med-2025-1201_ref_120","doi-asserted-by":"crossref","unstructured":"Guo J, Li G, Yang L. Role of H2S in pain: Growing evidences of mystification. Eur J Pharmacol. 2020 Sep;883:173322.","DOI":"10.1016\/j.ejphar.2020.173322"},{"key":"2025122201304113384_j_med-2025-1201_ref_121","doi-asserted-by":"crossref","unstructured":"Koroleva K, Ermakova E, Mustafina A, Giniatullina R, Giniatullin R, Sitdikova G. Protective effects of hydrogen sulfide against the ATP-induced meningeal nociception. Front Cell Neurosci. 2020 Sep;14:266.","DOI":"10.3389\/fncel.2020.00266"},{"key":"2025122201304113384_j_med-2025-1201_ref_122","doi-asserted-by":"crossref","unstructured":"Koroleva K, Mustafina A, Yakovlev A, Hermann A, Giniatullin R, Sitdikova G. Receptor mechanisms mediating the pro-nociceptive action of hydrogen sulfide in rat trigeminal neurons and meningeal afferents. Front Cell Neurosci. 2017 Jul;11:226.","DOI":"10.3389\/fncel.2017.00226"},{"key":"2025122201304113384_j_med-2025-1201_ref_123","doi-asserted-by":"crossref","unstructured":"Gopalakrishnan P, Shrestha B, Kaskas AM, Green J, Alexander JS, Pattillo CB. Hydrogen sulfide: Therapeutic or injurious in ischemic stroke? Pathophysiology. 2019 Mar;26(1):1\u201310.","DOI":"10.1016\/j.pathophys.2018.10.005"},{"key":"2025122201304113384_j_med-2025-1201_ref_124","doi-asserted-by":"crossref","unstructured":"Li T, Wang L, Hu Q, Liu S, Bai X, Xie Y, et al. Neuroprotective roles of l-cysteine in attenuating early brain injury and improving synaptic density via the CBS\/H2S pathway following subarachnoid hemorrhage in rats. Front Neurol. 2017 May;8:176.","DOI":"10.3389\/fneur.2017.00176"},{"key":"2025122201304113384_j_med-2025-1201_ref_125","doi-asserted-by":"crossref","unstructured":"Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O. Oxidative stress and antioxidant defense. World Allergy Organ J. 2012;5(1):9\u201319.","DOI":"10.1097\/WOX.0b013e3182439613"},{"key":"2025122201304113384_j_med-2025-1201_ref_126","doi-asserted-by":"crossref","unstructured":"Xie ZZ, Shi MM, Xie L, Wu ZY, Li G, Hua F, et al. Sulfhydration of p66Shc at cysteine59 mediates the antioxidant effect of hydrogen sulfide. Antioxid Redox Signal. 2014 Dec;21(18):2531\u201342.","DOI":"10.1089\/ars.2013.5604"},{"key":"2025122201304113384_j_med-2025-1201_ref_127","doi-asserted-by":"crossref","unstructured":"Jiang Z, Liu D, Li T, Gai C, Xin D, Zhao Y, et al. Hydrogen sulfide reduces oxidative stress in Huntington\u2019s disease via Nrf2. Neural Regener Res. 2025 Jun;20(6):1776\u201388.","DOI":"10.4103\/NRR.NRR-D-23-01051"},{"key":"2025122201304113384_j_med-2025-1201_ref_128","doi-asserted-by":"crossref","unstructured":"Liu Y, Gong Z, Zhai D, Yang C, Lu G, Wang S, et al. Unveiling the therapeutic potential of Dl-3-n-butylphthalide in NTG-induced migraine mouse: activating the Nrf2 pathway to alleviate oxidative stress and neuroinflammation. J Headache Pain. 2024 Apr;25(1):50.","DOI":"10.1186\/s10194-024-01750-1"},{"key":"2025122201304113384_j_med-2025-1201_ref_129","doi-asserted-by":"crossref","unstructured":"Kobayashi EH, Suzuki T, Funayama R, Nagashima T, Hayashi M, Sekine H, et al. Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription. Nat Commun. 2016 May;7(1):11624.","DOI":"10.1038\/ncomms11624"},{"key":"2025122201304113384_j_med-2025-1201_ref_130","doi-asserted-by":"crossref","unstructured":"Buendia I, Michalska P, Navarro E, Gameiro I, Egea J, Le\u00f3n R. Nrf2\u2013ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases. Pharmacol Ther. 2016 Jan;157:84\u2013104.","DOI":"10.1016\/j.pharmthera.2015.11.003"},{"key":"2025122201304113384_j_med-2025-1201_ref_131","doi-asserted-by":"crossref","unstructured":"Vurucu S, Karaoglu A, Paksu M, Yesilyurt O, Oz O, Unay B, et al. Relationship between oxidative stress and chronic daily headache in children. Hum Exp Toxicol. 2013 Feb;32(2):113\u20139.","DOI":"10.1177\/0960327112459204"},{"key":"2025122201304113384_j_med-2025-1201_ref_132","doi-asserted-by":"crossref","unstructured":"Cordero MD, Cano-Garc\u00eda FJ, Alcocer-G\u00f3mez E, De Miguel M, S\u00e1nchez-Alc\u00e1zar JA. Oxidative stress correlates with headache symptoms in fibromyalgia: Coenzyme Q10 effect on clinical improvement. Mendelson JE, editor. PLoS One. 2012 Apr;7(4):e35677.","DOI":"10.1371\/journal.pone.0035677"},{"key":"2025122201304113384_j_med-2025-1201_ref_133","doi-asserted-by":"crossref","unstructured":"Eren Y, Dirik E, Ne\u015felio\u011flu S, Erel \u00d6. Oxidative stress and decreased thiol level in patients with migraine: Cross-sectional study. Acta Neurol Belg. 2015 Dec;115(4):643\u20139.","DOI":"10.1007\/s13760-015-0427-y"},{"key":"2025122201304113384_j_med-2025-1201_ref_134","doi-asserted-by":"crossref","unstructured":"Edvinsson L, Haanes KA, Warfvinge K. Does inflammation have a role in migraine? Nat Rev Neurol. 2019 Aug;15(8):483\u201390.","DOI":"10.1038\/s41582-019-0216-y"}],"container-title":["Open Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2025-1201\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2025-1201\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T01:36:59Z","timestamp":1766367419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2025-1201\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":134,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,10,8]]},"published-print":{"date-parts":[[2025,10,8]]}},"alternative-id":["10.1515\/med-2025-1201"],"URL":"https:\/\/doi.org\/10.1515\/med-2025-1201","relation":{},"ISSN":["2391-5463"],"issn-type":[{"value":"2391-5463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,1]]},"article-number":"20251201"}}